Michael Schneider is a Senior Scientist in Medicinal Chemistry, specializing in Early Oncology at AstraZeneca since 2021. They previously completed a student internship in Medicinal Chemistry at Roche from 2015 to 2016. Michael earned a Bachelor of Science (B.Sc.) and a Master of Science (M.Sc.) in Chemistry from Eidgenössische Technische Hochschule Zürich, followed by a Doctor of Philosophy (Ph.D.) in Organic Chemistry from the same institution, completing their studies in 2021.
This person is not in the org chart
This person is not in any teams
This person is not in any offices